Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli

BACKGROUND/AIMS: The number of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is increasing. In an outpatient setting, there are limited therapeutic options to treat ESBL-producing pathogens. We evaluated the outcomes of amikacin outpatie...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Korean J Intern Med
Autori principali: Cho, Sung-Yeon, Choi, Su-Mi, Park, Sun Hee, Lee, Dong-Gun, Choi, Jung-Hyun, Yoo, Jin-Hong
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Association of Internal Medicine 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712420/
https://ncbi.nlm.nih.gov/pubmed/26767869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.31.1.156
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi